Preventative therapies for HIV-1 (Human Immunodeficiency Virus type 1) have made leaps and bounds over the past decade. A ...

Methodist College has partnered with the National Library of Medicine to bring a traveling exhibit to the college, raising ...

Jeremy Gregson was sitting in his Northwest Indiana home two years ago when he got the call that his blood work from earlier ...

The biggest barrier for those with HIV getting the care they need is not knowing they need it. In response, DAP Health is ...

Word In Black Mystkue Woods words to encourage, educate, and embolden folks take initiative in their sexual health journey by changing ...

The US Food and Drug Administration (FDA) has approved lenacapavir, an injectable drug that offers long-lasting protection ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

2:38 Risk of 2,000 new HIV infections daily after US aid freeze, UN AIDS agency estimates The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an ...

Why FDA approval of new HIV prevention drug is a big deal The U.S. Food and Drug Administration has approved the drug lenacapavir as a twice-yearly injection to prevent HIV.

The twice-yearly injectable drug’s potential could be compromised by the Trump administration’s dramatic cuts to HIV-prevention infrastructure in the U.S.

In 2012, the FDA approved Truvada, also made by Gilead Sciences, making it the first PrEP medication for HIV prevention in uninfected adults in the United States – but “even though PrEP has ...

FA new injection to prevent HIV is expected to be approved by the U.S. Food and Drug Administration (FDA) later this month. If approved, the shot—lenacapavir—would be given twice a year and ...